MAPPING OF ANTIVIRAL TARGETS IN THE ALPHAVIRUS PROTEOME AND ESTABLISHMENT OF RELEVANT INFECTION MODELS TO ASSESS ANTIVIRAL EFFECTS
Development and validation of a bona fide iPSC derived human neuronal infection model to evaluate antivirals targeted against neurotropic viral infections.
SYNERGY OF ENTRY INHIBITORS AND DIRECT ACTING ANTIVIRALS OR INTERFERON-ALFA IDENTIFIES NOVEL ANTIVIRAL COMBINATIONS FOR HEPATITIS C VIRUS INFECTION
Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives
Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial
Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-ofconcept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial